New Insights into the Pro-Inflammatory and Osteoclastogenic Profile of Circulating Monocytes in Osteoarthritis Patients

Paloma Guillem-Llobat,Marta Marín,Matthieu Rouleau,Antonio Silvestre,Claudine Blin-Wakkach,María Luisa Ferrándiz,María Isabel Guillén,Lidia Ibáñez

DOI: https://doi.org/10.3390/ijms25031710

IF: 5.6

2024-01-31

International Journal of Molecular Sciences

Abstract:Osteoarthritis (OA) is a degenerative condition of the articular cartilage with chronic low-grade inflammation. Monocytes have a fundamental role in the progression of OA, given their implication in inflammatory responses and their capacity to differentiate into bone-resorbing osteoclasts (OCLs). This observational–experimental study attempted to better understand the molecular pathogenesis of OA through the examination of osteoclast progenitor (OCP) cells from both OA patients and healthy individuals (25 OA patients and healthy samples). The expression of osteoclastogenic and inflammatory genes was analyzed using RT-PCR. The OA monocytes expressed significantly higher levels of CD16, CD115, TLR2, Mincle, Dentin-1, and CCR2 mRNAs. Moreover, a flow cytometry analysis showed a significantly higher surface expression of the CD16 and CD115 receptors in OA vs. healthy monocytes, as well as a difference in the distribution of monocyte subsets. Additionally, the OA monocytes showed a greater osteoclast differentiation capacity and an enhanced response to an inflammatory stimulus. The results of this study demonstrate the existence of significant differences between the OCPs of OA patients and those of healthy subjects. These differences could contribute to a greater understanding of the molecular pathogenesis of OA and to the identification of new biomarkers and potential drug targets for OA.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to understand the differences in the characteristics of osteoclast progenitor cells (OCPs) in circulating monocytes of patients with osteoarthritis (OA) from those of healthy individuals in terms of inflammation and osteoblastogenesis. Specifically, the study aims to reveal the molecular pathological mechanism of monocytes in OA patients by analyzing the osteoblastogenesis and inflammatory gene expression in monocytes of OA patients and healthy control groups, as well as the expression of these cell - surface markers. This helps to identify new biomarkers and potential drug targets, thus providing new ideas for the diagnosis and treatment of OA.

### Research Background
- **Osteoarthritis**: It is a disease mainly characterized by degenerative changes in articular cartilage, accompanied by chronic low - grade inflammation.
- **The role of monocytes**: It plays an important role in the progression of OA because it participates in the inflammatory response and can differentiate into osteoclasts (OCLs), which are responsible for bone resorption.
- **Research objective**: By comparing OCPs in circulating monocytes of OA patients and healthy individuals, explore their differences in terms of inflammation and osteoblastogenesis, in order to provide new insights into the molecular pathological mechanism of OA and discover potential biomarkers and drug targets.

### Main research contents
1. **Gene expression analysis**:
- RT - PCR was used to analyze the expression levels of osteoblastogenesis - and inflammation - related genes in monocytes of OA patients and healthy control groups. The results showed that the expressions of CD16, CD115, TLR2, Mincle, Dentin - 1 and CCR2 mRNAs in monocytes of OA patients were significantly higher than those in the healthy control group.

2. **Flow cytometry analysis**:
- The expressions of CD16 and CD115 receptors on the surface of monocytes of OA patients and healthy control groups were detected by flow cytometry. The results indicated that the expressions of CD16 and CD115 on the surface of monocytes of OA patients were significantly higher than those in the healthy control group.
- The expressions of CD115 and TLR2 in different subsets of monocytes (classical, intermediate and non - classical) were further analyzed. The results showed that the expression of CD115 in non - classical monocytes was significantly increased in OA patients.

3. **Monocyte subset analysis**:
- The proportions of classical (CD14 ++/CD16−), intermediate (CD14 ++/CD16+) and non - classical (CD14 +/CD16++) monocytes in OA patients and healthy control groups were compared. The results found that the proportion of classical monocytes was significantly increased in OA patients.

4. **Osteoblastogenesis ability analysis**:
- The osteoblastogenesis abilities of monocytes in OA patients and healthy control groups were evaluated by in vitro experiments. The results showed that monocytes in OA patients exhibited stronger abilities in osteoblastogenesis, and the number of TRAP - positive multinucleated osteoblasts formed was significantly increased.

### Conclusion
This study revealed significant differences in circulating monocytes of OA patients in terms of inflammation and osteoblastogenesis. These differences may help to better understand the molecular pathological mechanism of OA and provide new potential targets for the diagnosis and treatment of the disease.